Targeting JNK for therapeutic benefit: from junk to gold?
Top Cited Papers
- 1 July 2003
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 2 (7) , 554-565
- https://doi.org/10.1038/nrd1132
Abstract
The c-Jun NH2-terminal kinases (JNKs) phosphorylate and activate members of the activator protein-1 (AP-1) transcription factor family and other cellular factors implicated in regulating altered gene expression, cellular survival and proliferation in response to cytokines and growth factors, noxious stimuli and oncogenic transformation. Because these events are commonly associated with the pathogenesis of a number of human diseases, the potential of JNK inhibitors as therapeutics has attracted considerable interest. Here we discuss the evidence supporting the application of JNK inhibitors in inflammatory, vascular, neurodegenerative, metabolic and oncological diseases in humans, and describe the present status of drug discovery targeting JNK.Keywords
This publication has 78 references indexed in Scilit:
- The specificities of protein kinase inhibitors: an updateBiochemical Journal, 2003
- A central role for JNK in obesity and insulin resistanceNature, 2002
- The c-Jun NH2-terminal kinase3 (JNK3) gene: genomic structure, chromosomal assignment, and loss of expression in brain tumorsJournal of Human Genetics, 2001
- Protein kinase inhibitors: emerging pharmacophores 1997 - 2000Expert Opinion on Therapeutic Patents, 2001
- CEP-1347 (KT7515), a Semisynthetic Inhibitor of the Mixed Lineage Kinase FamilyPublished by Elsevier ,2001
- Inhibitors of the JNK signaling pathwayDrugs of the Future, 2001
- Hyperinsulinemia: the missing link among oxidative stress and age-related diseases?Free Radical Biology & Medicine, 2000
- c-Jun N-terminal Kinase Is Essential for Growth of Human T98G Glioblastoma CellsPublished by Elsevier ,2000
- Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascadesOncogene, 1997
- The stress-activated protein kinase subfamily of c-Jun kinasesNature, 1994